Frank X. Leonard, EVP, President, Novocure Oncology at NovoCure Ltd (NVCR), sold 598 shares at $15.94 ($10K) on 2024-11-01, disclosed to the SEC on 2024-11-04.
Open-market sale of $10k NVCR by EVP, President, Novocure Oncology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NVCR | SELL | 2026-03-03 | $231K | — | Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |